TNS Development After HoLEP Surgery May Be Influenced by Patient Positioning, Procedure Duration, and Patient Characteristics
American Society of Regional Anesthesia and Pain Medicine (ASRA)A retrospective chart review found a 3.7% occurrence rate of transient neurologic symptoms (TNS) in patients receiving 1.5% mepivacaine during Holmium Laser Enucleation of the Prostate (HoLEP) surgery and suggested a possible association of TNS development with quicker procedures, smaller prostates, lithotomy positioning, and younger age.